Four-Pronged attack on Tough-to-Treat colon cancer
NCT ID NCT05627635
Summary
This study is testing a new combination of four drugs for people with a common type of advanced colorectal cancer that has spread. The goal is to find the safest and most effective dose and see if this four-drug approach can help control the cancer. It combines standard chemotherapy with two newer immunotherapy drugs and one drug that blocks tumor blood supply.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.